Stay updated on 12-Week Psoriasis Dose-Ranging Clinical Trial
Sign up to get notified when there's something new on the 12-Week Psoriasis Dose-Ranging Clinical Trial page.

Latest updates to the 12-Week Psoriasis Dose-Ranging Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page displays a new Revision: v3.4.2 banner and the former government funding lapse notice is removed; core study details remain unchanged.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a government funding notice with status links (cc.nih.gov, opm.gov) and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedThe page adds a glossary toggle and updates metadata labels and revision information (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0) while removing the previous QC label and alternate capitalization (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4. No content changes are indicated.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 to the page footer. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check91 days agoChange DetectedThe Publications section description was updated to indicate automatic population from PubMed. The revision label was updated to v3.3.2, replacing the previous v3.2.0 wording.SummaryDifference0.1%

Stay in the know with updates to 12-Week Psoriasis Dose-Ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 12-Week Psoriasis Dose-Ranging Clinical Trial page.